Literature DB >> 17003923

Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.

Berthold Hoppe1, Farzaneh Tolou, Thomas Dörner, Holger Kiesewetter, Abdulgabar Salama.   

Abstract

Evolvement and progression of cardiovascular diseases affecting the venous and arterial system are influenced by a multitude of environmental and hereditary factors. Many of these hereditary factors consist of defined gene polymorphisms, such as single nucleotide polymorphisms (SNPs) or insertion-deletion polymorphisms, which directly or indirectly affect the hemostatic system. The frequencies of individual hemostatic gene polymorphisms in different normal populations are well defined. However, descriptions of patterns of genetic variability of a larger extent of different factors of hereditary hypercoagulability in single populations are scarce. The aim of this study was i) to give a detailed description of the frequencies of factors of hereditary thrombophilia and their combinations in a German population (n = 282) and ii) to compare their distributions with those reported for other regions. Variants of coagulation factors [factor V 1691G>A (factor V Leiden), factor V 4070A>G (factor V HR2 haplotype), factor VII Arg353Gln, factor XIII Val34Leu, beta-fibrinogen -455G>A, prothrombin 20210G>A], coagulation inhibitors [tissue factor pathway inhibitor 536C>T, thrombomodulin 127G>A], fibrinolytic factors [angiotensin converting enzyme intron 16 insertion/deletion, factor VII-activating protease 1601G>A (FSAP Marburg I), plasminogen activator inhibitor 1-675 insertion/deletion (5G/4G), tissue plasminogen activator intron h deletion/insertion], and other factors implicated in influencing susceptibility to thromboembolic diseases [apolipoprotein E2/E3/E4, glycoprotein Ia 807C>T, methylenetetrahydrofolate reductase 677C>T] were included. The distribution of glycoprotein Ia 807C>T deviated significantly from the Hardy-Weinberg equilibrium, and a comparison with previously published data indicates marked region and ethnicity dependent differences in the genotype distributions of some other factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003923

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community?

Authors:  Rami A R Mahfouz; Amira S Sabbagh; Dina M R Shammaa; Zaher K Otrock; Ghazi S Zaatari; Ali T Taher
Journal:  Mol Biol Rep       Date:  2007-05-22       Impact factor: 2.316

2.  Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrity.

Authors:  Nurbek Mambetsariev; Tamara Mirzapoiazova; Bolot Mambetsariev; Saad Sammani; Frances E Lennon; Joe G N Garcia; Patrick A Singleton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-30       Impact factor: 8.311

3.  The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.

Authors:  Ruta Sahasrabudhe; Jacob Stultz; John Williamson; Paul Lott; Ana Estrada; Mabel Bohorquez; Claire Palles; Guadalupe Polanco-Echeverry; Emma Jaeger; Lynn Martin; Maria Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal-Carmona
Journal:  J Clin Endocrinol Metab       Date:  2015-12-21       Impact factor: 5.958

4.  Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality.

Authors:  Stella Trompet; Douwe Pons; Sandip M Kanse; Anton J M de Craen; M Arfan Ikram; Jeffrey J W Verschuren; Aeilko H Zwinderman; Pieter A F M Doevendans; René A Tio; Robbert J de Winter; P Eline Slagboom; Rudi G J Westendorp; J Wouter Jukema
Journal:  Stroke Res Treat       Date:  2011-06-30

5.  Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.

Authors:  R Dambrauskienė; R Gerbutavičius; R Ugenskienė; R Jankauskaitė; A Savukaitytė; R Šimoliūnienė; M Rudžianskienė; R Gerbutavičienė; E Juozaitytė
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

6.  VEGF-A-Cleavage by FSAP and Inhibition of Neo-Vascularization.

Authors:  Özgür Uslu; Joerg Herold; Sandip M Kanse
Journal:  Cells       Date:  2019-11-06       Impact factor: 6.600

7.  HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.

Authors:  Tamara Mirzapoiazova; Nurbek Mambetsariev; Frances E Lennon; Bolot Mambetsariev; Joshua E Berlind; Ravi Salgia; Patrick A Singleton
Journal:  Front Oncol       Date:  2015-07-21       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.